MY199261A - Long-acting conjugate of triple glucagon/glp-1/gip receptor agonist - Google Patents
Long-acting conjugate of triple glucagon/glp-1/gip receptor agonistInfo
- Publication number
- MY199261A MY199261A MYPI2018001199A MYPI2018001199A MY199261A MY 199261 A MY199261 A MY 199261A MY PI2018001199 A MYPI2018001199 A MY PI2018001199A MY PI2018001199 A MYPI2018001199 A MY PI2018001199A MY 199261 A MY199261 A MY 199261A
- Authority
- MY
- Malaysia
- Prior art keywords
- glp
- long
- receptor agonist
- gip receptor
- acting conjugate
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20150191082 | 2015-12-31 | ||
| PCT/KR2016/015555 WO2017116205A1 (fr) | 2015-12-31 | 2016-12-30 | Conjugué persistant d'un triple activateur activant le récepteur du glucagon, du glp-1 et du gip |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY199261A true MY199261A (en) | 2023-10-23 |
Family
ID=62104015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2018001199A MY199261A (en) | 2015-12-31 | 2016-12-30 | Long-acting conjugate of triple glucagon/glp-1/gip receptor agonist |
Country Status (3)
| Country | Link |
|---|---|
| AR (2) | AR107281A1 (fr) |
| MA (4) | MA42891B2 (fr) |
| MY (1) | MY199261A (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3842449A1 (fr) * | 2019-12-23 | 2021-06-30 | Merck Sharp & Dohme Corp. | Co-agonistes d'oléfine agrafés du glucagon et récepteurs glp-1 |
-
2016
- 2016-12-30 MY MYPI2018001199A patent/MY199261A/en unknown
- 2016-12-30 MA MA42891A patent/MA42891B2/fr unknown
- 2016-12-30 MA MA42889A patent/MA42889B2/fr unknown
- 2016-12-30 MA MA51955A patent/MA51955B1/fr unknown
-
2017
- 2017-01-02 AR ARP170100003A patent/AR107281A1/es unknown
- 2017-01-02 AR ARP170100004A patent/AR107282A1/es unknown
-
2018
- 2018-07-26 MA MA53533A patent/MA53533A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA42891A1 (fr) | 2019-04-30 |
| MA53533A1 (fr) | 2022-08-31 |
| AR107281A1 (es) | 2018-04-18 |
| MA51955B1 (fr) | 2022-04-29 |
| MA42889A1 (fr) | 2018-11-30 |
| MA51955A1 (fr) | 2021-10-29 |
| MA42889B2 (fr) | 2020-11-30 |
| MA42891B2 (fr) | 2021-11-30 |
| AR107282A1 (es) | 2018-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2018000231A1 (en) | Long-acting conjugate of triple glucagon/glp-1/gip receptor agonist | |
| MX2020003217A (es) | Coagonistas de accion prolongada de los receptores de glucagon y glp-1. | |
| TN2017000555A1 (en) | Glucagon derivative and a composition comprising a long acting conjugate of the same | |
| IL256748A (en) | New exendin-4 derivatives as selective peptidic dual glp-1 / glucagon receptor agonists | |
| IL266985A (en) | Agents as peptide agonists for glp1/glucagon/gip receptors | |
| IL247834A0 (en) | Exendin-4 derivatives as dual peptides that are glp-1/glucagon agonists | |
| MX2016005560A (es) | Compuestos agonistas triples de glucagon-glp-1-gip. | |
| WO2017074798A3 (fr) | Co-agonistes à action longue durée des récepteurs du glucagon et du glp-1 | |
| CA3013532A1 (fr) | Liraglutide utilise dans le traitement de maladies cardiovasculaires | |
| MY199261A (en) | Long-acting conjugate of triple glucagon/glp-1/gip receptor agonist | |
| HK1228923A1 (en) | Dual glp-1 / glucagon receptor agonists derived from exendin-4 | |
| HK1229341A1 (en) | Exendin-4 derivatives as peptidic dual glp-1 / glucagon receptor agonists |